Protalix BioTherapeutics (PLX) Interest Coverage Ratio (2011 - 2025)
Protalix BioTherapeutics' (PLX) quarterly Interest Coverage Ratio came in at 5.32 in Q4 2025, down 103.03% year-on-year from 175.83 in Q4 2024, and down 214.16% quarter-over-quarter from 4.66 in Q3 2025.
Protalix BioTherapeutics (PLX) Interest Coverage Ratio (2011 - 2025) Analysis & Trends
Protalix BioTherapeutics' Interest Coverage Ratio history runs 15 years deep, the most recent figure standing at 5.32 for Q4 2025.
- On a quarterly basis, Interest Coverage Ratio fell 103.03% year-over-year to 5.32 in Q4 2025; TTM through Mar 2026 was 14.86, a 169.36% increase from a year earlier, with the FY2025 full-year figure at 0.11, down 241.25% from the prior year.
- Interest Coverage Ratio fell to 5.32 in Q4 2025 per PLX's latest filing, from 4.66 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 175.83 in Q4 2024 and bottomed at 690.83 in Q1 2025.
- The 5-year median for Interest Coverage Ratio is 4.1 (2023), against an average of 31.32.
- Across the five-year window, Interest Coverage Ratio surged 1468.43% in 2024 and sank 10797.41% in 2025, its largest moves.
- Year by year, Interest Coverage Ratio stood at 46.77 in 2021, then jumped by 91.79% to 3.84 in 2022, then plunged by 234.74% to 12.85 in 2023, then jumped by 1468.43% to 175.83 in 2024, then plunged by 103.03% to 5.32 in 2025.
- Per Business Quant, the three latest PLX Interest Coverage Ratio figures stand at 5.32 (Q4 2025), 4.66 (Q3 2025), and 690.83 (Q1 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | Protalix BioTherapeutics | 190.95 Mn | 180.16 Mn | 29.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5.32 |
| Sep 30, 2025 | 4.66 |
| Mar 31, 2025 | -690.83 |
| Dec 31, 2024 | 175.83 |
| Sep 30, 2024 | 9.66 |
| Jun 30, 2024 | -6.40 |
| Mar 31, 2024 | -6.34 |
| Dec 31, 2023 | -12.85 |
| Sep 30, 2023 | -4.10 |
| Jun 30, 2023 | 15.65 |
| Mar 31, 2023 | -2.28 |
| Dec 31, 2022 | -3.84 |
| Sep 30, 2022 | -4.89 |
| Jun 30, 2022 | -8.87 |
| Mar 31, 2022 | -1.67 |
| Dec 31, 2021 | -46.77 |
| Sep 30, 2021 | -0.78 |
| Jun 30, 2021 | -4.16 |
| Mar 31, 2021 | -1.72 |
| Dec 31, 2020 | -1.01 |